Submitted by Anonymous (not verified) on 31 July 2025 - 15:30
Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 27, Status: Authorised
Source: